Aiforia Technologies

3,85

EUR

-2,53 %

1.936 følger denne virksomhed

AIFORIA

First North Finland

Medical Equipment & Services

Health Care

Overview

Finansielt overblik og estimater

Investor consensus

-2,53%

+4,9%

+5,48%

+9,69%

-8,98%

-3,02%

-14,46%

-

-23,91%

Aiforia Technologies equips pathologists and researchers in preclinical and clinical laboratories with software to translate images into discoveries, decisions and diagnoses. The company's products and services are used for medical image analysis, across a variety of areas from oncology to neuroscience. Aiforia Technologies is headquartered in Finland.

Markedsværdi

111,51 mio. EUR

Aktieomsætning

162,76 t EUR

P/E (adj.) (25e)

-10,3

EV/EBIT (adj.) (25e)

-10,1

P/B (25e)

8,54

EV/S (25e)

25,55

Udbytteafkast, % (25e)

-

Coverage

Anbefaling

Akkumulér

Kursmål

4.20 EUR

Opdateret

23.04.2025

Antti Luiro, Frans-Mikael Rostedt

Latest research

Seneste analyse

Released: 24.04.2025

Seneste omfattende analyse

Released: 24.04.2025

Omsætning og EBIT-margin

Omsætning mio.

EBIT-% (adj.)

EPS og udbytte

EPS (adj.)

Udbytte %

Finanskalender

28.8

2025

Delårsrapport Q2'25

Risiko

Business risk

Valuation risk

Lav

Høj

Alle

Analyse

Selskabspræsentationer

Selskabsmeddelelser

ViserAlle indholdstyper

Aiforia Extensive Report: Track open for market takeover

Omfattende analyse24.4.2025, 20.33 af

Antti Luiro, Frans-Mikael Rostedt

Aiforia Extensive Report: Track open for market takeover

Aiforia has become the market leader in clinical pathology image recognition, winning the majority of new contracts in the market in recent years.

Aiforia Technologies

Selskabsmeddelelse16.4.2025, 06.00

Aiforia Technologies Plc: Share subscriptions based on stock options 2020 II

Aiforia Technologies

Selskabsmeddelelse7.4.2025, 08.00

Aiforia Technologies Plc – Managers’ Transactions – Jukka Tapaninen

Aiforia Technologies

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account

Followings and notifications on followed companies

Analyst comments and recommendations

Stock comparison tool & other popular tools

Selskabsmeddelelse4.4.2025, 12.00

Resolutions of Aiforia Technologies Plc’s Annual General Meeting 2025

Aiforia Technologies

Selskabsmeddelelse1.4.2025, 06.30

Change in Aiforia Technologies Plc’s Management Team

Aiforia Technologies

Pressemeddelelse24.3.2025, 12.00

Aiforia and USCAP extend collaboration to support eLearning for pathologists

Aiforia Technologies

Analytikerkommentar24.3.2025, 06.25 af

Antti Luiro, Frans-Mikael Rostedt

Aiforia's image recognition models also available on the PathPresenter platform

PathPresenter is developing a workflow system for pathologists that integrates models from multiple image analysis solution providers (such as Aiforia).

Aiforia Technologies

Pressemeddelelse21.3.2025, 12.00

Aiforia partners with PathPresenter to accelerate the adoption of digital pathology and AI

Aiforia Technologies

Analytikerkommentar21.3.2025, 11.50 af

Antti Luiro, Frans-Mikael Rostedt

Aiforia’s partnership with Techcyte offers an alternative to the structure of the market’s future value chain

The partnership will, in principle, promote market formation and support the strong revenue growth we forecast for Aiforia, although there are nuances to the matter.

Aiforia Technologies

Pressemeddelelse21.3.2025, 07.00

Aiforia and Techcyte announce strategic collaboration to advance AI-powered digital pathology

Aiforia Technologies

Analytikerkommentar18.3.2025, 08.45 af

Antti Luiro, Frans-Mikael Rostedt

Aiforia’s partner network expands to Canada

New partnerships are naturally positive for Aiforia, as they reflect the attractiveness of the company's image analysis solutions in the digital pathology market and improve the prerequisites for winning new customers.

Aiforia Technologies

Pressemeddelelse18.3.2025, 07.00

Aiforia expands its global reach through a partnership with Quorum Technologies in Canada

Aiforia Technologies

Selskabsmeddelelse14.3.2025, 07.00

Aiforia Technologies Plc Publishes its Board of Directors’ Report and Financial Statements for 2024

Aiforia Technologies

Selskabsmeddelelse13.3.2025, 07.00

Notice of Aiforia Technologies Plc’s Annual General Meeting 2025

Aiforia Technologies

Selskabsmeddelelse12.3.2025, 15.30

Aiforia Technologies Plc – Managers’ Transactions – Jukka Tapaninen

Aiforia Technologies

Aiforia H2'24: The fruits of customer wins are ripening

Analyse10.3.2025, 11.04 af

Antti Luiro, Frans-Mikael Rostedt

Aiforia H2'24: The fruits of customer wins are ripening

Aiforia continued to build its impressive market position in clinical pathology image analysis.

Aiforia Technologies

Selskabsmeddelelse10.3.2025, 10.00

Aiforia Technologies Plc – Managers’ Transactions – Jukka Tapaninen

Aiforia Technologies

Aiforia, Webcast, Q4'24

Videopræsentation7.3.2025, 08.00

Aiforia, Webcast, Q4'24

Aiforia Technologies

Selskabsmeddelelse7.3.2025, 07.00

Aiforia Technologies Plc’s Financial Statements Bulletin for January–December 2024: Aiforia’s market position and orderbook strengthened

Aiforia Technologies

Analytikerkommentar7.3.2025, 06.12 af

Antti Luiro, Frans-Mikael Rostedt

Aiforia selected as partner for Sardinia’s regional health authority

Aiforia announced that the Sardinian region health authorities in Italy have selected the company as their partner for image analysis for clinical diagnostics in pathology.

Aiforia Technologies

Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.